Bruker (BRKRP) Interest Coverage Ratio (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.73% |
| Dec 31, 2025 | 366.98% |
| Sep 30, 2025 | -436.66% |
| Jun 30, 2025 | -68.78% |
| Mar 31, 2025 | -47.48% |
| Dec 31, 2024 | -21.27% |
| Sep 30, 2024 | 91.62% |
| Jun 30, 2024 | -76.36% |
| Mar 31, 2024 | -44.90% |
| Dec 31, 2023 | -26.31% |
| Sep 30, 2023 | 44.43% |
| Jun 30, 2023 | -24.34% |
| Mar 31, 2023 | -4.11% |
| Dec 31, 2022 | -14.15% |
| Sep 30, 2022 | 292.08% |
| Jun 30, 2022 | -178.49% |
| Dec 31, 2014 | 626.53% |
| Sep 30, 2014 | -86.59% |
| Jun 30, 2014 | 66.30% |
| Mar 31, 2014 | -54.97% |
| Dec 31, 2013 | 54.92% |
| Sep 30, 2013 | -29.85% |
| Jun 30, 2013 | 256.56% |
| Mar 31, 2013 | -58.84% |
| Dec 31, 2012 | -46.09% |
| Sep 30, 2012 | 180.88% |
| Jun 30, 2012 | -39.43% |
| Mar 31, 2012 | -51.47% |
| Dec 31, 2011 | -2.62% |
| Sep 30, 2011 | -8.80% |
| Jun 30, 2011 | 41.17% |
| Mar 31, 2011 | -46.87% |
| Dec 31, 2010 | -1.53% |
| Sep 30, 2010 | 12.34% |